Directory → Hormones and their antagonists → Insulins → Insuman rapid
This page is translated automatically with a help of Google Translate
Insuman rapidSee also human InsulinRoman nameRapid InsumanOf drugsWhereas deficiency of endogenous (produced in the body) insulin diabetes, lowers the level of glucose in the blood. Refers to products identical human insulino, rapid and short-acting. After subcutaneous injections of there in half an hour, reaches a maximum at 1-2 hours and lasts, depending on the dose of 5-8 hours.Storage conditionsList B. In the dark place (in the original carton) with a temperature of 2 ° C to 8 ° C. Avoid freezing.Indications for useInsulinozawisimy diabetes; Diabetic coma (loss of consciousness, characterized by the complete lack of reaction of the organism to external stressors, as a consequence of excessive levels of blood sugar); Prekomatosnoe state (/ partial loss of consciousness / initial stage of coma characterized by continuing pain and Reflective reactions); Metabolic (acidification); intermittirutego for (periodic) of the diabetics in the face of infection accompanied by fever, surgery, injuries, childbirth, metabolic disorders before going for treatment drugs insulin average duration of the (insulin comb) to be added to the drug prolonged insulin (long) acts (insuman bazal) with the expressed io (raising blood sugar).Dosing and AdministrationDose prepared individually and depend on the degree of io, glukozurii (level of sugar in the urine), to the course of the disease. The average single dose for adults is 166 U, for children and the high degree of sensitivity to insulino doses can be lower than 8 U. The recommended interval between injections and reception food is 15-20 minutes. The agent introduced subcutaneously and intravenously.Side-EffectsAllergic reactions to insulin, or preservative, lipodistrofia (decrease of adipose tissue in subcutaneous tissue), resistance insulino (no reaction to the imposition of insulin).ContraindicationsHypoglycaemia (to reduce blood sugar), high sensitivity to components of the preparation.Form ofSolution neutral insulin injection (1 ml product contains 40 U and 0.0027 m-krezola (preservative) to 10 ml in vials; Insuman rapid for Opti Pena in cartridges to 3 ml (1 ml of 40 U). |
All products of this group |

